Health
Study shows persisting cognitive benefits of common Alzheimer’s treatment – News-Medical.net
Cholinesterase inhibitors are a group of drugs recommended for the treatment of Alzheimer’s disease, but their effects on cognition have been debated and few studies…
Cholinesterase inhibitors are a group of drugs recommended for the treatment of Alzheimer’s disease, but their effects on cognition have been debated and few studies have investigated their long-term effects. A new study involving researchers from Karolinska Institutet in Sweden and published in the journal Neurology shows persisting cognitive benefits and reduced mortality for up to five years after diagnosis.
Alzheimer’s disease is a cognitive brain disease that affects millions of patients around…
-
Noosa News24 hours agoLaidley e-scooter death: Tragic new details after Summah Richards killed in freak accident
-
General18 hours agoUkraine says Russia has ramped up attacks despite ‘Easter truce’
-
General20 hours agoReason v magical climate thinking – voters have no choice
-
General17 hours agoPope Francis appears Easter Sunday to deliver blessing as recovery continues